X-104250529-G-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting

The ENST00000372588.4(ESX1):​c.920C>T​(p.Pro307Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000916 in 1,092,213 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000092 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.0000092 ( 0 hom. 4 hem. )

Consequence

ESX1
ENST00000372588.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.00400
Variant links:
Genes affected
ESX1 (HGNC:14865): (ESX homeobox 1) This gene encodes a dual-function 65 kDa protein that undergoes proteolytic cleavage to produce a 45 kDa N-terminal fragment with a paired-like homeodomain and a 20 kDa C-terminal fragment with a proline-rich domain. The C-terminal fragment localizes to the cytoplasm while the N-terminal fragment localizes exclusively to the nucleus. In contrast to human, the mouse homolog has a novel PN/PF motif in the C-terminus and is paternally imprinted in placental tissue. This gene likely plays a role in placental development and spermatogenesis. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06794274).
BS2
High Hemizygotes in GnomAdExome4 at 4 geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ESX1NM_153448.4 linkuse as main transcriptc.920C>T p.Pro307Leu missense_variant 4/4 ENST00000372588.4 NP_703149.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ESX1ENST00000372588.4 linkuse as main transcriptc.920C>T p.Pro307Leu missense_variant 4/41 NM_153448.4 ENSP00000361669 P1

Frequencies

GnomAD3 genomes
AF:
0.00000919
AC:
1
AN:
108781
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
31581
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000299
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000244
AC:
2
AN:
82105
Hom.:
0
AF XY:
0.0000958
AC XY:
2
AN XY:
20881
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000139
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000258
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000915
AC:
9
AN:
983432
Hom.:
0
Cov.:
32
AF XY:
0.0000130
AC XY:
4
AN XY:
308556
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000391
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000561
Gnomad4 NFE exome
AF:
0.00000381
Gnomad4 OTH exome
AF:
0.0000490
GnomAD4 genome
AF:
0.00000919
AC:
1
AN:
108781
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
31581
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000299
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000185
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 28, 2022The c.920C>T (p.P307L) alteration is located in exon 4 (coding exon 4) of the ESX1 gene. This alteration results from a C to T substitution at nucleotide position 920, causing the proline (P) at amino acid position 307 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
5.0
DANN
Benign
0.59
DEOGEN2
Benign
0.26
T
FATHMM_MKL
Benign
0.0079
N
LIST_S2
Benign
0.59
T
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.068
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
0.81
L
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
0.16
N
REVEL
Benign
0.13
Sift
Benign
0.033
D
Sift4G
Benign
0.42
T
Polyphen
0.40
B
Vest4
0.10
MutPred
0.29
Loss of glycosylation at P307 (P = 0.0293);
MVP
0.28
MPC
0.41
ClinPred
0.023
T
GERP RS
0.18
Varity_R
0.035
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782469730; hg19: chrX-103495210; API